Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
Tango Therapeutics (NASDAQ: TNGX) said CEO Barbara Weber, M.D. will deliver a corporate presentation at the 44th Annual J.P.
Rhea-AI Summary
Tango Therapeutics (NASDAQ: TNGX) said CEO Barbara Weber, M.D. will deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 9:45am PST / 12:45pm EST.
The presentation will be streamed live via the Investors > Events & Presentations page on the company's website, and a replay will be archived on the website for 90 days after the event.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TNGX
In the Dec 17 session, TNGX declined 2.01%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Presentation date
- January 14, 2026
- J.P. Morgan Healthcare Conference corporate presentation
- Presentation time
- 9:45am PST / 12:45pm EST
- Scheduled conference session start time
- Webcast replay duration
- 90 days
- Replay archived on company website
- Share price
- $8.96
- Price prior to conference participation news
- 52-week range
- $1.03 – $11.20
- 52-week low and high for TNGX
- Market cap
- $1,228,255,097
- Equity value prior to the announcement
- Today’s volume
- 2,255,536 shares
- Compared with 20-day average of 2,688,245
- Resale shares registered
- 1,732,101 shares
- S-3 resale registration filed November 21, 2025
Historical Context
-
Announcement of participation in Piper Sandler healthcare conference with webcast replay.
-
Jefferies healthcare conference fireside chat announcement with webcast access.
-
Q3 2025 profit, cash position, and multiple oncology program updates.
-
Scheduling notice for Q3 2025 financial results release without conference call.
-
Underwritten offering and PIPE totaling about $225M in gross proceeds.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 9:45am PST/12:45pm EST.
The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Elizabeth Hickin
IR@tangotx.com
media@tangotx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.